Florenzano P, Jimenez M, Ferreira CR, Nesterova G, Roberts MS, Tella SH, Fernandez de Castro L, Gafni RI, Wolf M, Juppner H, Gales B, Wesseling-Perry K, Markovich D, Gahl WA, Salusky IB, Collins MT (2020) Nephropathic cystinosis: a distinct form of CKD-mineral and bone disorder that provides novel insights into the regulation of FGF23
Regulatory Status It's important to note that Epithalon is not currently approved by the FDA for therapeutic use in the United States
However, this does not definitively exclude the possibility that some patients may experience back pain during therapy
Nuclear factor erythroid-2-related factor 2 gene polymorphisms in vitiligo